Search

Your search keyword '"Dorff T"' showing total 7 results
Start Over Author "Dorff T" Topic castration-resistant prostate cancer
7 results on '"Dorff T"'

1. 609O Results from a phase I study of AMG 160, a half-life extended (HLE), PSMA-targeted, bispecific T-cell engager (BiTE®) immune therapy for metastatic castration-resistant prostate cancer (mCRPC).

Author

Tran, B., Horvath, L., Dorff, T., Rettig, M., Lolkema, M.P., Machiels, J-P., Rottey, S., Autio, K., Greil, R., Adra, N., Lemech, C., Minocha, M., Cheng, F-C., Kouros-Mehr, H., and Fizazi, K.

Subjects
*CASTRATION-resistant prostate cancer, *T cells
Published
2020
Full Text
View/download PDF

2. 1765O Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC).

Author

Kelly, W., Danila, D., Lin, C-C., Lee, J-L., Matsubara, N., Ward, P., Armstrong, A.J., Pook, D., Kim, M., Dorff, T., Fischer, S., Lin, Y-C., Horvath, L.G., Sumey, C., Yang, Z., Jurida, G., Connarn, J., Penny, H., Stieglmaier, J., and Appleman, L.J.

Subjects
*CASTRATION-resistant prostate cancer, *CD3 antigen
Published
2023
Full Text
View/download PDF

3. 264P Interim results from a phase I study of AMG 509 (xaluritamig), a STEAP1 x CD3 XmAb 2+1 immune therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).

Author

Kelly, W.K., Danila, D.C., Lin, C-C., Lee, J-L., Matsubara, N., Ward, P.J., Armstrong, A.J., Pook, D.W., Kim, M., Dorff, T., Fischer, S., Lin, Y-C., Horvath, L.G., Sumey, C., Yang, Z., Jurida, G., Connarn, J., Penny, H., Stieglmaier, J., and Appleman, L.J.

Subjects
*CASTRATION-resistant prostate cancer, *CD3 antigen
Published
2023
Full Text
View/download PDF

5. 580P TALAPRO-1: Talazoparib (TALA) monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) - Exploration of non-DDR mutational landscape and potential associations with antitumor activity.

Author

Mehra, N., de Bono, J., Laird, A.D., Barthélémy, P., Delva, R., Dorff, T., Maruzzo, M., Stirling, A., Machiels, J-P., Dumez, H., Renard, V., Hopkins, J., Albacker, L.A., Chen, H-C., Healy, C., Chelliserry, J., van Oort, I.M., Scagliotti, G., and Fizazi, K.

Subjects
*DNA repair, *CASTRATION-resistant prostate cancer, *DNA damage
Published
2021
Full Text
View/download PDF

6. 1368P TALAPRO-1: Talazoparib monotherapy in metastatic castration-resistant prostate cancer (mCRPC) with DNA damage response alterations (DDRm) – Exploration of tumor genetics associated with prolonged benefit.

Author

de Bono, J.S., Castro Marcos, E., Laird, D.A., Fizazi, K., Dorff, T., Zhao, S., van Oort, I.M., Gasparro, D., Calabrò, F., Pignata, S., Geczi, L., Barthelemy, P., Kilari, D., Hopkins, J.F., Chen, H-C., Healy, C.G., Chelliserry, J., Scagliotti, G.V., and Mehra, N.

Subjects
*CASTRATION-resistant prostate cancer, *DNA damage, TUMOR genetics
Published
2022
Full Text
View/download PDF

7. 138P TALAPRO-1: Talazoparib (TALA) monotherapy in men with DNA damage response alterations (DDRalt) and metastatic castration-resistant prostate cancer (mCRPC): Exploration of DDRalt germline/somatic origin.

Author

Mehra, N., Fizazi, K., Laird, A.D., Barthélémy, P., Delva, R., Dorff, T., Maruzzo, M., Stirling, A., Machiels, J-P., Dumez, H., Renard, V., Albacker, L.A., Hopkins, J., Chen, H-C., Mata, M., Di Santo, N., Healy, C.G., van Oort, I.M., Buttigliero, C., and de Bono, J.S.

Subjects
*CASTRATION-resistant prostate cancer, *DNA damage, *GERM cells, *SOMATIC mutation
Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results